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The Government’s approach to 
minimising harm from alcohol and 
other drug misuse needs to be 
compassionate, innovative and 
proportionate. This recognises 
that alcohol and other drug 
problems are first and foremost 
health issues. 
Compassion is crucial. Help 
needs to be available for those 
who need it, interventions need  
to happen early, and the stigma 
that acts as a barrier to help 
seeking and recovery needs to be 
reduced. This National Drug  
Policy emphasises the need for  
a people-centred intervention 
system that is responsive to 
people’s circumstances, 
environment and life stages. 
We also have to be prepared to 
challenge traditional approaches 
and ways of thinking about these 
issues. Innovation is essential  
in a world where new drugs are 
detected every week and the black 
market has gone digital. The 
international landscape has also 
shifted, with a growing recognition 
that the harms we are trying to 
prevent can come from our 
approach to drugs as much as  
from their use.
Different drugs have different risk 
profiles and our responses to them 
need to reflect this. In some cases, 
such as with methamphetamine, 
we want to eradicate all supply and 
use. For alcohol, we want those who 
choose to drink to do so moderately 
and those who are pregnant or 
planning pregnancy not to drink at 
all. When legislating to try and 
reduce harmful behaviour we need 
to ensure the rules and penalties we 
implement are both proportionate 
to the potential for harm and 
evidence-based. 
In relation to alcohol, the 
Government has already responded 
by tightening the rules on the sale 
of alcohol and putting more control 
in the hands of local communities 
through the Sale and Supply of 
Alcohol Act 2012, reducing the 
blood-alcohol limit for driving and 
increasing alcohol screening and 
brief interventions in primary care. 
Actions are also included in this 
National Drug Policy as the 
Government’s response to the Law 
Commission’s recommendations  
on the Misuse of Drugs Act 1975. 
These relate to ensuring the Expert 
Advisory Committee on Drugs has 
appropriate decision-making 
guidance, ensuring appropriate 
access to controlled drugs for 
medical purposes (while minimising 
the risk of diversion), and assessing 
options for possession and utensils 
offences to incorporate an 
enhanced health response. 
New Zealand continues to make 
strong progress in minimising 
alcohol and other drug harm. 
Hazardous consumption of alcohol 
has decreased over the last six 
years from 18 percent in 2006/07 to 
16 percent in 2013/14. The Prime 
Minister’s Methamphetamine 
Action Plan has helped to more 
than halve the reported rates of 
amphetamine use. The combined 
focus on restricting the supply of 
methamphetamine and its 
precursors, with treatment and 
community-based initiatives has 
contributed to this reduction.
There is still, however, a lot to do. 
The Government has set a range of 
Better Public Services targets and 
other social sector initiatives to 
make New Zealand a better place to 
live for all New Zealanders. These 
targets and initiatives include 
reducing long-term welfare 
dependence, supporting vulnerable 
children, boosting skills and 
employment, and reducing crime. 
When we dig beneath the surface  
of many of the issues we need to 
address to achieve these outcomes, 
we find that misuse of alcohol and 
drugs is a contributing factor. 
There is no quick fix. Progress will 
take time, and will require 
coordinated action across the social 
sector and other agencies to 
understand where to target 
resources and provide wrap-around 
support. Partnership with non-
governmental organisations, 
businesses, communities and 
families will also be vital in 
minimising alcohol and other drug 
related harm. As Minister 
responsible for this Government’s 
policy on alcohol and other drugs,  
I will work with my ministerial 
colleagues to ensure not only that 
agencies have a coordinated 
approach to this issue, but that we 
work with those who deliver 
services and interventions to make 
New Zealand a better place. 
Hon Peter Dunne 
Associate Minister of Health
Foreword
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The National Drug Policy sets out our response as a society to alcohol and other 
drug1 (AOD) issues. The Government will use the Policy to prioritise its resources 
and assess the effectiveness of the actions taken by government agencies and 
frontline services. 
The Policy aims to guide, influence and support decision-making by local 
services, communities and non-governmental organisations, and in doing so, 
improve collaboration and maximise the effectiveness of the system as a whole.
New Zealand has  
high rates of alcohol 
and other drug use
Over a lifetime 44 percent of  
New Zealanders will have tried an 
illegal drug and 93 percent will 
have drunk alcohol (Ministry of 
Health 2015b). A number of adults 
aged 15+ use illegal drugs:
 → 1 in 13 smoke cannabis at  
least once a month (Ministry  
of Health 2015b)2
 → 1 in 37 have used ecstasy  
in the last year(Ministry of 
Health 2015b)
 → 1 in 100 have used amphetamine 
in the last year (Ministry of 
Health 2014c).
Some people are psychologically  
or physiologically dependent on 
these substances. This means they 
have become so used to having 
AOD in their system they need to 
keep using them in order to 
function normally. It is estimated 
that 12 percent of the population 
will experience a substance use 
disorder at some stage in their 
lives (Wells et al 2007). 
Additionally, a recent study found 
that approximately 11 percent of 
New Zealand secondary school 
students use substances at a level 
that are likely to cause them 
significant current harm and may 
cause long-term problems (The 
University of Auckland 2014).
Misuse of AOD  
harms individuals, 
communities and 
society
While not every instance of  
AOD use is harmful, the effects 
of these substances can be 
significant. Immediate harms 
related to AOD use include falls, 
road accidents and the clogging  
up of hospital accident and 
emergency departments. Harms 
can also arise over the long term, 
such as AOD-related health 
conditions, relationship issues  
and difficulty obtaining and 
maintaining employment. 
Introduction
1. Other drugs include: substances classified under the Medicines Act 1981 or Misuse of Drugs Act 1975 and not used within the controls set out in legislation 
or for their intended purpose; substances captured by the Psychoactive Substances Act 2013; and other substances such as solvents and aerosols.
2. Data for cannabis and ecstasy use in the last 12 months (as at 2012/13) are provisional and potentially subject to revision or change until they have been 
through the full quality assurance process and received final approval for release.
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For example, approximately 4500 
people receiving a health-related 
benefit have a primary diagnosis  
of alcohol or substance abuse  
and a quarter of these people  
have received a benefit for at least 
10 years.
AOD-related harm does not occur 
in a vacuum. The harm experienced 
depends on a complicated web of 
factors, including the substance(s) 
involved, the extent of use, the 
method of use, the vulnerabilities 
of the person using AOD, and the 
environment in which AOD is used.
Harmful impacts of AOD are not 
restricted to the individual using 
the substance. Examples of 
AOD-related harm to others 
include violence, foetal AOD 
exposure, family break-up and 
child neglect, property crime and 
public health issues such as the 
spread of hepatitis.
Problematic AOD use is often 
multi-generational and can be 
normalised within family and 
whānau groups. Such patterns of 
behaviour may also normalise 
actions that will bring people, 
particularly young people, into 
contact with the criminal justice 
system, such as cannabis offences 
or drink driving. 
Particular populations often 
experience a disproportionate 
amount of harm. For this Policy to 
be successful, harm needs to be 
minimised for all populations.
Taking action to 
minimise harm 
means looking at 
the whole picture
AOD policy cannot be viewed in 
isolation from social factors (such 
as income, employment, housing 
and education) that may make 
people more at risk of being 
affected, directly or indirectly, by 
harm from AOD. Effective 
government intervention requires 
a cross-agency response. Health 
care, education and social services, 
alongside the justice system, 
communities, families and whānau 
play critical roles in minimising 
harm from AOD.
The complexity of these issues 
means that our responses need  
to be flexible, targeting the  
needs of different populations, 
family and whānau situations and 
environments, and responding  
to emerging issues early. 
Approaches need to be evaluated, 
tested and refined using domestic 
and international evidence and 
best practice.
New Zealand is not alone in  
facing the challenge of reducing 
harm caused by AOD. We can learn 
from international practice, policy 
and structures. This includes 
international agreements, such 
as the United Nations Drug 
Conventions, trade agreements and 
human rights instruments. The 
Government will monitor innovative 
approaches as they are tested 
internationally, including 
experimental regimes that make 
cannabis available for medicinal use. 
An investment-
based approach 
ensures support 
goes where it will 
make the biggest 
difference
Harmful use of AOD has been 
estimated to cost our country 
around $6.5 billion each year 
(Business and Economic Research 
Limited 2009). This includes the 
cost to healthcare of responding 
to AOD related accidents, illnesses 
and injuries, the cost of welfare 
payments for people who have 
become incapacitated through 
substance dependence and the 
costs to the criminal justice 
system of enforcing AOD-related 
legislation.
By focussing on prevention and 
early intervention at the 
population level, through to 
targeted, people-centred 
responses for those individuals 
who need greater support, we can 
reduce these harms and their flow 
on effects to families, whānau, 
communities and the wider public. 
The Policy’s first Priority Area for 
action is targeted specifically at 
ensuring a people-centred 
intervention system. 
  National Drug Policy 2015 to 2020 3
A collaborative 
response to AOD 
harm is needed
There are many people and 
organisations – including district 
health boards, service providers, iwi 
and hapū groups, schools, churches 
and community organisations – 
making a difference by minimising 
AOD-related harm and working  
to promote and protect health  
and wellbeing. Indeed, everyone 
can have a role in minimising  
AOD harm.
 → Individuals can take action  
to reduce harmful use.
 → Family, whānau and friends  
can support someone to make 
changes in their use. 
 → Community members and 
leaders can advocate for 
positive AOD policies in 
community settings such as  
a local sports club, and also 
model responsible AOD use.
 → Educational institutions can 
introduce policies to support 
students struggling with  
AOD issues to stay engaged  
in education.
 → Employers can offer a chance  
to people who are in the process 
of recovering from substance 
dependence.
 → Frontline services can provide 
appropriate interventions, plans 
and treatment for those who 
need help.
Government agencies have a  
role by collaborating, supporting 
and partnering with others to 
achieve common goals. In 
particular, the principles of 
partnership, participation and 
protection will continue to 
underpin the relationship between 
government and Māori to achieve 
pae ora3 and health equity by 
supporting the health and 
wellbeing aspirations of Māori.
The Government is 
committed to 
getting results
The Government has instructed the 
Inter-Agency Committee on Drugs 
(IACD) to oversee the 
implementation of actions and 
monitor progress made against the 
objectives set out in this Policy. The 
Inter-Agency Committee on Drugs 
brings together chief executives of 
the Ministries of Health, Justice,  
Social Development, and Education, 
the New Zealand Police, the 
Department of Corrections, and  
the New Zealand Customs Service. 
The Accident Compensation 
Corporation, National Drug 
Intelligence Bureau, Health 
Promotion Agency and Te Puni 
Kōkiri also participate at the 
working group level. This collection 
of agencies will ensure integration 
between the delivery of this Policy 
and broader Social Sector 
objectives.
The IACD will report to the 
Government annually. Their  
advice will cover progress on 
implementing actions, whether 
objectives are being achieved, and 
any changes to actions and 
timelines that may be required as 
evidence emerges. The IACD will 
also provide advice on whether 
achieving the objectives of this 
Policy is helping to drive progress 
on the government’s broader social 
sector goals, including the Better 
Public Services Result Areas. 
3. Pae ora is a holistic concept including three interconnected elements of mauri ora (healthy individuals), whanau ora (healthy families) and wai ora (healthy 
environments). Pae ora is also the Government’s vision for Māori health and can be accessed through http://www.health.govt.nz/our-work/populations/
maori-health/he-korowai-oranga/pae-ora-healthy-futures.
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Our approach for 
the next five years
The Government’s approach over the next five years includes a shared goal, 
objectives, strategies and priorities for action. This approach, and its 
contribution to wider social sector outcomes, is summarised in Figure 1 and 
discussed in detail in the rest of the chapter.
A shared goal  
provides a  
foundation for  
collaboration
The goal of this Policy is to 
minimise AOD-related harm and 
promote and protect health and 
wellbeing for all New Zealanders. 
The idea of harm minimisation 
encompasses the prevention and 
reduction of health, social and 
economic harms experienced by 
individuals, their families and 
friends, communities and society 
from AOD use. The promotion and 
protection of wellbeing integrates 
physical, mental and social needs 
to strengthen protective factors 
for individuals, families and 
communities. 
Making progress towards this  
goal will impact on wider social 
objectives, and in particular four  
of the Better Public Services  
Result Areas in relation to 
reducing welfare dependency, 
supporting vulnerable children, 
boosting skills and employment 
and reducing crime. 
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Figure 1: The framework for the National Drug Policy 2015–2020
Objectives
Delaying the uptake of 
AOD by young people
Reducing illness and 
injury from AOD
Reducing hazardous 
drinking of alcohol
Shifting our attitudes 
towards AOD
Contribution to social sector outcomes
Reducing welfare 
dependency
Supporting 
vulnerable children
Boosting skills and 
employment
Reducing crime
Goal
To minimise AOD-related harm and promote and protect health and wellbeing.
Strategies
Problem limitation
Barriers to people accessing 
and receiving support or 
treatment for their own or 
others’ AOD use are removed
Demand reduction
People have the knowledge, 
skill and support to make 
good decisions about their 
AOD use
Supply control
Access to AOD for harmful  
use is minimised
Priority areas 
Creating a 
people-centred 
intervention 
system
Getting the 
legal balance 
right
Improving 
information 
flow
Shifting 
thinking and 
behaviour
Disrupting 
organised crime
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Clear objectives 
focus us on results
As well as having a shared goal,  
we need clear objectives to provide 
a focus over the entire life of the 
Policy. These objectives are: 
 → delayed uptake of AOD by  
young people 
 → reduced AOD-related illness  
and injury
 → reduced hazardous drinking 
of alcohol
 → a shift in attitudes towards 
AOD. 
Progress on these objectives will 
mean progress on reducing overall 
harm from AOD. To know whether 
progress is being made, high-level 
indicators and measures have 
been developed. These will be 
based on the latest available data 
and will enable high-level trends  
to be assessed.
Evidence-based 
strategies ensure  
we are doing the 
right things
This Policy provides a structure  
for the wide range of activity 
already being undertaken by  
the Government and others to 
minimise harm and to promote and 
protect wellbeing. The activities can 
be categorised under three broad 
strategies, or ‘pillars’: problem 
limitation, demand reduction and 
supply control. These pillars are 
underpinned with high quality  
data to ensure the right balance 
and targeting of activity. These 
strategies also act as a guide for 
new initiatives. 
The approach is similar to that used 
in other countries, including the 
United Kingdom, Australia and many 
nations in the European Union.
Problem limitation aims to 
reduce harm that is already 
occurring to those who use AOD or 
those affected by someone else’s 
AOD use. It includes activities that 
provide safer equipment and 
environments for AOD use, ensure 
access to quality AOD treatment 
services through New Zealand’s 
health system, and support people 
in recovery. It also includes 
activities that support others who 
are affected, such as the children of 
people with dependence problems. 
Demand reduction aims to 
reduce the desire to use AOD.  
It includes activities that delay  
or prevent uptake. This means 
reducing use through education, 
health promotion, advertising and 
marketing restrictions, and 
influencing the conditions that 
make people turn to AOD through 
community action, such as keeping 
children in school.
Supply control aims to prevent 
or reduce the availability of  
AOD. It includes controlling  
New Zealand’s borders to prevent 
illegal drugs being imported,  
and shutting down domestic 
growing, manufacturing and 
supply. It also aims to control  
and manage the supply of legal 
drugs through things like 
prescribing guidelines, age 
restrictions, licensing conditions 
and permitted trading hours.
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Our priorities enable 
us to achieve results 
This Policy identifies five areas 
that will require additional focus 
over the next five years if the 
Government is to make meaningful 
progress against the objectives: 
 → Priority area 1: creating a people-
centred intervention system
 → Priority area 2: shifting thinking 
and behaviour
 → Priority area 3: getting the legal 
balance right
 → Priority area 4: disrupting 
organised crime 
 → Priority area 5: improving 
information flow.
Each priority area has an initial set 
of actions to be undertaken by 
2017/18. These actions are drawn 
from across the three strategies 
and build on, rather than replace, 
the significant contributions 
government, communities and 
individuals already make to the 
goal and objectives of this Policy.
Many of the initial actions are 
designed to enhance collaboration 
and links across government, 
service providers and communities 
in order to achieve better outcomes 
collectively than can be achieved 
alone. This collaborative approach 
recognises that everyone has a role 
in minimising AOD-related harm, 
but that the Government has a 
responsibility to lead.
The initial actions are also 
designed to build a foundation to 
better enable individuals, families 
and communities to contribute to 
the Policy’s goals and objectives, 
and to support prevention and 
intervention activity, particularly 
for young people. 
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Delaying  
the uptake  
of AOD by 
young people
Around 75 percent of people who develop a 
substance use disorder (eg. substance abuse  
or dependence) will do so by the age of 25  
(Wells et al 2007).
By age 15 one in four people have drunk alcohol  
and one in six have used an illegal drug (Ministry  
of Health 2015a and 2015b).
By the age of 21 approximately 80 percent of young  
New Zealanders will have used cannabis, with  
10 percent developing a pattern of heavy, dependent 
use (Office of the Prime Minister’s Science Advisory 
Committee and Gluckman 2011). 
Early uptake of AOD 
is a predictor for 
ongoing problems, 
including substance 
use and dependence.
Early use of AOD raises very 
serious issues for our children  
and society. The brain does not 
fully mature until the third decade 
of life, and the evidence suggests 
that exposure to AOD during 
adolescence and young adulthood 
may interrupt important 
neurological processes and natural 
brain maturation. This can have 
consequences for social and 
neurobiological functioning in 
adulthood (Squeglia et al 2009; 
Office of the Prime Minister’s 
Science Committee and Gluckman 
2011). This is more likely when 
people start using AOD earlier 
(early onset) and do so regularly  
or heavily. 
Early onset of alcohol consumption 
tends to increase the likelihood of 
regular and heavy use and has been 
associated with increased rates of 
violence and injury, unprotected 
sex, mental health problems, 
suicide, poorer educational 
outcomes and problem drinking 
later in life (Dawson et al 2008; 
Fergusson et al 1994; Hingston et al 
2006, 2009; Komro et al 2010; 
Office of the Prime Minister’s 
Science Advisory Committee, 2011; 
Swahn et al 2010). Of adults aged  
15 years and over who reported 
drinking hazardously in the past  
12 months 48 percent had first 
used alcohol before age 15  
(Ministry of Health 2015b).
Our objectives
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The evidence highlights that early 
onset of cannabis use also tends 
to increase the likelihood of 
misuse, as well as mental health 
issues, other illicit drug use, school 
drop-out and educational 
underachievement, neurocognitive 
deficits and injury (Meier et al. 
2012; Office of the Prime Minister’s 
Science Advisory Committee 2011; 
Silins et al 2014).
Early use and misuse of AOD is 
linked to a range of social and 
environmental factors, including 
exposure to traumatic life 
experiences such as child abuse 
and neglect, family violence and 
household dysfunction (Office of 
the Prime Minister’s Science 
Committee and Gluckman 2011). 
The way young people socialise 
can also influence use. We know 
people are more likely to use drugs 
such as cannabis when their peers 
are doing so (Kuntsche and 
Delgrande 2006) and that social 
and parental modelling influences 
youth AOD use. There is also a 
strong genetic component to AOD 
issues (Office of the Prime 
Minister’s Science Advisory 
Committee 2011). 
The way that we respond to young 
people’s use of AOD can have 
life-long consequences. 
Accordingly, the Prime Minister’s 
Chief Science Advisor warns 
against responding punitively to 
behaviours that reflect incomplete 
maturation (Office of the Prime 
Minister’s Chief Science Advisor 
2011). Drugs (excluding alcohol) 
were the second most prevalent 
reason cited by school boards for 
exclusions4 in 2013, accounting for 
17 percent, and the main reason for 
expulsions5, at 34 percent (Ministry 
of Education 2013). Not being able 
to participate fully in school life 
can limit a young person’s ability 
to gain employment, sustain 
relationships and make life 
choices. Similarly, consequences 
from interaction with the criminal 
justice system from low-level 
AOD-related offending can be far 
reaching. During 2013/14 (ie, fiscal 
year ending 30 June 2014) 2410 
police proceedings6 for illicit drug 
possession or use against youth 
(aged 5–24) were recorded, with 
approximately a quarter resulting 
in court action.7 
Table 1: Indicator for delaying the uptake of AOD by young people 
Indicator of success Delayed uptake of alcohol and other drugs by young people
Measure Initiation of first use as reported by adults aged 15+ years 
Data source New Zealand Health Survey (5 yearly)
(Alcohol) Baseline 2012/13 
Under 15: 27%; 15-19: 60%; 20-24: 10%
(Other drugs) Baseline: 2012/138  
14 and under: 16%; 15-17: 33%; 18-20: 29%
4. Exclusion means the formal removal of a student aged under 16 from the school and the requirement that the student enrol elsewhere.
5. Expulsion means the formal removal of a student aged 16 or over from the school. If the student wishes to continue schooling, he or she may enrol 
elsewhere.
6. Proceedings include court action, formal and informal warnings, non-court referred conferences and other non-court action.
7. These figures have been produced from a statistical dataset that is still under development, and which will, in the future be used to produce Recorded 
Crime Offender Statistics. Those Tier 1 statistics should be available from 1 July 2015.
8. Data for other drug use in the last 12 months (as at 2012/13) are provisional and potentially subject to revision or change until they have been through 
the full quality assurance process and received final approval for release.
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Reducing 
illness  
and injury 
from AOD
Approximately 12 percent of New Zealanders will 
experience a substance use disorder at some stage 
in their lives (Oakley et al 2006).
AOD use accounts for about 5 percent of all health 
loss9 experienced by New Zealanders and 23 percent 
of mental illness, mainly through substance use 
disorders. Alcohol comprises the majority of this 
loss (3.9% and 18% respectively) (Ministry of Health 
2013b). 
Sharing needles and other drug utensils remains  
the key route for hepatitis C virus transmission in 
New Zealand. Eighty-three percent of people with 
hepatitis C virus infection report a history of 
intravenous drug use (Gane et al 2014).
AOD misuse  
has serious 
consequences  
for the health of 
New Zealanders. 
AOD taken recreationally produces 
physiological changes to the body. 
These effects are generally 
intended to be pleasurable, but 
they also have the potential to 
cause considerable harm to the 
people that use them and to 
others. Each year about 150,000 
New Zealanders aged 16 and older 
experience substance use problems 
that could benefit from an 
intervention (Mental Health 
Commission 2011). Different drugs 
also carry different risk profiles and 
the impact on individuals will vary 
depending on their vulnerabilities, 
environmental and social 
circumstances and patterns of use.
Around 800 deaths per year are 
attributable to alcohol. Injuries are 
the dominant cause of alcohol-
attributable deaths for people 
under 45, with alcohol-induced 
cancers becoming increasingly 
dominant from the age of 45 
(Connor et al 2013). Alcohol-
attributable injuries are estimated 
to account for 11 percent of all ACC 
claims, at a cost of $350 million 
per year (Accident Compensation 
Corporation 2012).
Regular and heavy cannabis 
smokers are at increased risk of 
contracting chronic bronchitis, 
respiratory infections and 
pneumonia when compared to 
9. Health loss is a measure of how much healthy life is lost due to early death, illness or disability.
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non-smokers and may suffer 
cancers of the lung (Room et  
al 2008).
Large doses of methamphetamine 
can cause potentially life-
threatening conditions, such as 
hypothermia, renal and liver failure, 
cardiac arrhythmias, heart attacks, 
strokes and seizures (Krasnova  
& Cadet, 2009; Drake et al 2008). 
The long-term health impacts of 
frequent methamphetamine use 
can include respiratory problems, 
stroke, irregular heartbeat, 
anorexia, and neurotoxicity as well 
as affecting cardiovascular health, 
and cognitive functioning (Drake  
et al 2008).
Rates of accidental poisonings 
(including overdose) are higher for 
opioids such as heroin, methadone 
and codeine than for any other 
illegal drug in New Zealand. These 
substances are also the most likely 
to be injected, which can cause vein 
damage and increase exposure to 
communicable diseases. Availability 
of clean equipment will reduce 
harm: the introduction of the 1-for-1 
needle exchange has reduced the 
rate of hepatitis C infection among 
people who currently inject drugs 
by around 25 percent (Noller and 
Henderson, 2014; Henderson  
et al 2011). 
Additionally, stopping use of 
alcohol or other drugs after daily 
or frequent use over a couple of 
months can trigger withdrawal 
symptoms. Most people will 
experience mild to moderate 
symptoms, but for some, the 
effects will be more serious (for 
example, alcohol and 
benzodiazepine withdrawal can be 
fatal (Bayard et al 2004; Lann and 
Molina 2009)). 
Relapse is common, and people 
who have stopped using even for  
a short period of time are at risk  
of over-dosing should they resume 
use. Relapse prevention plans and 
transition plans between services 
– for example from specialist care 
to primary care – are important 
tools to assist people with recovery.
Reducing illness and injury from 
AOD includes having a focus on 
other people who are affected by 
an individual’s use, particularly 
children. For example:
 → AOD misuse is  a factor in  
25 percent of families with 
children in Child, Youth and 
Family care (Office of the Chief 
Social Worker 2014) 
 → alcohol was a contributing 
factor in 34 percent of all family 
violence incidents in 2007/08 
(Ministry of Justice 2010).
 → for every 100 alcohol or drug-
impaired drivers or riders who 
died in road crashes, 47 of their 
passengers and 17 sober road 
users died with them (Ministry 
of Transport 2014).
Table 2: Indicator for reducing illness and injury from AOD
Indicator of success Reduced AOD-related illness and injury
Measure Alcohol-related emergency department presentations
Data source Ministry of Health National Collections data (annual) 
Baseline to be established in 2015/16
Measure Accidental poisoning by exposure to opioids 
Data source Mortality collection, Ministry of Health
2011 baseline: 39
Measure People receiving a health-related benefit where primary diagnosis  
is listed as alcohol or substance abuse 
Data source Ministry of Social Development
March 2015 baseline: 4,435
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10. Ministry of Health, 2014b. The Alcohol Use Disorders Identification Test (AUDIT) developed by the World Health Organization is used to identify hazardous 
drinking patterns. The AUDIT is a 10-item questionnaire covering alcohol consumption, alcohol-related problems, and abnormal drinking behaviour.  
Each question is scored from 0 to 4, so the questionnaire has a maximum score of 40. An AUDIT score of 8 or more is defined as hazardous drinking. 
Reducing 
hazardous 
drinking of 
alcohol
Men (22 percent) are twice as likely as women  
(11 percent) to drink hazardously.
One in three 18–24-year-olds drink at levels that are 
hazardous to their health (Ministry of Health 2014b).
Alcohol contributes to around 30 percent of  
New Zealand’s fatal road crashes (Ministry of 
Transport 2014).
Approximately 10 percent of women drink heavily 
during pregnancy (Ministry of Health 2015a).
One in six  
New Zealand adults 
have hazardous 
drinking patterns.10
It is encouraging that both total 
and hazardous consumption of 
alcohol by New Zealanders aged 
15+ has reduced over the last six 
years (Ministry of Health, 2014b).
 → The proportion of the adult 
population who drink has 
decreased from 84 percent in 
2006/07 to 80 percent in 
2013/14. 
 → The proportion who drink 
hazardously has decreased from 
18 percent in 2006/07 to 16 
percent in 2013/14. 
Despite these positive trends, the 
rates of hazardous drinking 
continue to be high. Approximately 
575,000 New Zealanders report 
drinking in a way that carries a risk 
of harm to themselves and others 
around them. Additionally, while 
total and hazardous consumption 
of alcohol by young people aged 
18-24 also decreased between 
2006/07 and 2013/14 (from 89 to 
84 percent and 43 to 33 percent 
respectively) this group remains 
most likely to drink hazardously 
(Ministry of Health, 2014b). 
Hazardous drinking can contribute 
to a number of social harms – not 
just to individuals, but also to 
those around them. The most 
common harmful effects reported 
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by adults due to someone else’s 
drinking are damage to friendships 
and social life, and damage to 
home life and financial position 
(Ministry of Health 2010). Alcohol 
consumption is also a factor in 
offending behaviour. Police 
estimate that at least one-third of 
recorded violent offences and  
15 percent of sexual offences occur 
after the offender has consumed 
alcohol (New Zealand Police 2009).
Babies exposed to alcohol before 
birth can develop lifelong 
problems, including behavioural 
problems, intellectual disability 
and heart defects. This can lead to 
poor life outcomes and increased 
risk of involvement with the 
criminal justice and welfare 
systems. There is no cure for Fetal 
Alcohol Spectrum Disorders 
(FASD), but they are preventable. 
For women who are pregnant or 
planning a pregnancy, the safest 
option is to avoid drinking alcohol. 
New Zealand has relatively high 
rates of alcohol consumption 
during pregnancy, with up to a third 
of New Zealand women consuming 
some alcohol while pregnant, and 
around 10 percent drinking heavily 
(Morton et al, 2010; Mallard et al, 
2013; Ministry of Health 2015a). The 
Health Select Committee’s Inquiry 
into Improving Child Health 
Outcomes and Preventing Child 
Abuse, with a Focus from Pre-
conception until Three years of  
Age identified estimates of the 
number of babies born each year  
in New Zealand with FASD ranging 
from 173 to 3000. 
There is also evidence that 
parental alcohol use can harm 
children. Children with parents or 
caregivers who drink heavily are 
likely to suffer from a greater 
number of hospital admissions for 
physical injuries (Families 
Commission 2006). Children raised 
by caregivers who are alcohol 
dependent can have higher levels 
of anxiety, behavioural problems 
and other mental health issues 
than children who do not have 
alcohol-dependent parents 
(Maynard 1997). Research also 
suggests that children of alcohol-
dependent parents are more  
likely to become alcohol 
dependent themselves, creating 
generational impacts (Jennison 
and Johnson 1998). 
Table 2: Indicator for reducing hazardous drinking of alcohol
Indicator of success New Zealand past-year drinkers who report hazardous drinking patterns
Measure Hazardous drinking score (AUDIT) in past-year drinkers  
aged 15 years and over
Data source New Zealand Health Survey (annual)
2011/12 Baseline: 19%
Measure Women who had been pregnant in the last 12 months  
and drank during most recent pregnancy
Data source New Zealand Health Survey (5 yearly)
2012/13 Baseline: 19%
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Shifting our 
attitudes 
towards AOD
Six percent of all adult past-year drinkers planned to  
get drunk on their most recent drinking occasion, 
and 12 percent reported having ‘got drunk or had 
too much to drink’ on their most recent drinking 
occasion (Research New Zealand 2014).
Twenty-five percent of high school age students 
thought it was okay for people their age to drink 
alcohol, and 10 percent thought it was okay to use 
cannabis (almost the same number as for cigarettes) 
(Adolescent Health Research Group 2013).
Around 50,000 people wanted help to reduce  
their AOD use in the past 12 months but had, for a 
variety of reasons, not received it (Mental Health 
Commission 2011).
Social attitudes 
towards AOD can 
promote misuse and 
act as barriers to 
help-seeking and 
recovery.
Our attitudes are a key predictor of 
our behaviour. They are shaped by 
our individual values and beliefs, 
the values and beliefs of our peers 
and people of influence, and by our 
surroundings, such as the 
messages we are exposed to and 
the rules set by the Government. 
People use AOD for many reasons, 
including enjoyment of the effects, 
relaxation, alleviation of stress or a 
depressed mood, to enhance an 
activity, to better bond with peers, 
and to keep awake at night to 
socialise (Boys et al 2001; Duff 
2008; Jay 1999). Young people 
have also reported that they have 
used drugs to ‘fit in’ with peers, to 
cope with problems, to relieve 
boredom, and to rebel (Ministry  
of Health 2009b). 
Environmental factors contribute 
to AOD use and can be a barrier to 
help-seeking and recovery. These 
factors include ease of access to 
substances, the presence of 
violence in the home, peer 
pressure, unemployment, and/or 
mental health issues. Such factors 
can in turn be exacerbated by  
AOD use. 
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In most cases AOD use is not 
problematic. For example, many 
people enjoy moderate 
consumption of alcohol in social 
settings with few ill effects. 
However, harm can result when 
people misuse AOD, particularly 
when social patterns of misuse and 
intoxication become entrenched.
There are many reasons why 
people who feel they need help for 
their AOD use might not seek 
assistance to do so. These include 
not being ready to stop use, not 
knowing where to go for help or 
encountering long waiting lists, 
and being concerned about the 
potential negative effects on 
employment, or that receiving help 
might cause others to have a 
negative opinion of them (Ministry 
of Health 2009b). For example, a 
dedicated methamphetamine 
telephone helpline service found 
that many callers were deeply 
concerned about confidentiality 
because of such fears. Information 
that allowed them to self-manage 
their issues was often considered 
more important than seeing a 
counsellor. Offering people a 
variety of choices for treatment is 
more likely to change behaviour 
than limiting support to only a few 
options. Several studies have 
found that substance use 
disorders are more highly 
stigmatised than other health 
conditions (Livingston et al 2012). 
Stigma can also impact people’s 
recovery journey. For many people, 
recovery means assuming some 
control over their lives. This means 
being able to be better parents, to 
be employed, and to live as others 
do. This can be difficult if they 
encounter discrimination for their 
past actions. As well as their AOD 
use, their offending histories can 
severely limit future possibilities, 
for example, cannabis convictions 
can limit someone’s ability to 
travel overseas, or to get a job.
Over the medium to long term, 
achieving our objectives will 
require shifting the attitudes of 
individuals and communities to 
AOD use and misuse, and to 
seeking help. But, as we have seen 
with tobacco and drink-driving,  
it is possible to shift attitudes  
over time.
Table 4: Indicator for shifting our attitudes towards AOD
Indicator of success Shifting our attitudes towards AOD
Measure Adults aged 15+ who sought or have been given advice, 
information or help on how to cut back their drinking  
in the last 12 months11
Data source HPA Alcohol Behaviours and Attitudes Survey (annual)
Baseline 2013: 5%
Measure AOD outcome measure for AOD treatment services
Data source AOD treatment services reporting requirements to the  
Ministry of Health 
Baseline to be established in 2015/16
11. Note that this question is only asked of people who had consumed two or more drinks on their last drinking occasion (within the last three months). 
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Our strategies
In order to achieve these objectives and move towards the goal of minimising 
AOD harm and promoting and protecting health and wellbeing, we need clear 
strategies for action. This Policy carries over from previous policies the three 
strategies for action of problem limitation, demand reduction and 
supply control.
Current activities by government, communities, families and individuals can  
be categorised under one or more of these strategies, and these strategies  
act as a guide for the development of new initiatives. The three strategies,  
and examples of activities, are described in Table 5.
Table 5: National Drug Policy strategies and example activities
Problem limitation
Barriers are removed to people accessing and receiving 
support or treatment for their own or others’ AOD use
New Zealand is working in this area to:
 → provide effective, high-quality, compassionate, timely, accessible, 
and age- and culture-appropriate support and treatment services
 → address the factors that have an impact on people’s ability  
to access treatment and support, including destigmatising  
help-seeking
 → provide AOD services that are responsive to people with  
co-existing problems
 → ensure all frontline services (justice, health, education, etc.) 
provide an entry point to AOD support, referral and treatment 
(including for the child affected by a parent’s addiction)
 → support and strengthen harm reduction approaches such as the 
needle exchange programme
 → ensure continuity of care for people transitioning from one service 
or environment to another, including from youth to adult services, 
and between justice facilities and the community.
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Demand reduction
People have the knowledge, skill and support to make good 
decisions about their AOD use
New Zealand is working in this area to:
 → ensure messages about AOD harm, harm reduction and help-
seeking (including information about less harmful consumption 
and means of administration) are consistent, evidence-based, 
accessible and relevant
 → tailor messages, resources and services appropriately to respond 
to different cultures, populations and communities
 → encourage women to abstain from AOD use (or use less harmful 
substitutions, such as methadone, where appropriate) during 
pregnancy and while breast feeding
 → bring about a societal shift in attitudes about harmful AOD use.
Supply control
Access to AOD for harmful use is minimised
New Zealand is working in this area to achieve:
 → legislation and enforcement that can respond to changing 
environments and new technologies
 → enforcement action that seeks prevention and has broad coverage 
(eg. border control), while also targeting substances, environments 
and organisations (such as gangs) that cause the most harm
 → effective detection of substances and enforcement of the law 
relating to the importation, manufacture and distribution of drugs 
for illegal use
 → effective regulation and monitoring of the supply chain for 
prescription drugs.
All three strategies 
are needed
Often they work well together,  
but sometimes they come into 
conflict and require a balancing 
act. For example, fear of the legal 
consequences of using an illegal 
drug can act as a barrier to some 
people seeking the help they need. 
In these instances, assessment  
of the best available evidence is 
needed to determine which mix  
of approaches is required to best 
address social, economic and 
health harms. This is harm 
minimisation in action.
18 National Drug Policy 2015 to 2020
Our priorities for 
Government action
Five areas have been identified to focus on if we are to make meaningful 
progress towards achieving our objectives. These have been labelled:
→ Priority area 1: creating a people-centred intervention system
→ Priority area 2: shifting thinking and behaviour 
→ Priority area 3: getting the legal balance right
→ Priority area 4: disrupting organised crime
→ Priority area 5: improving information flow.
This Policy makes a commitment 
to an initial set of actions, and 
these will be reviewed and 
updated by the end of 2017. The 
actions are drawn from across the 
three strategies and will build on, 
rather than replace, the significant 
contributions that government, 
communities and individuals 
already make to the goal and 
objectives of this Policy. 
The AOD landscape continues to 
evolve, and new evidence will 
continue to emerge about the 
issues that need to be addressed 
and the effectiveness of the 
interventions aimed at addressing 
them. The IACD will review the 
progress made and emerging 
evidence, and will provide advice 
on a revised set of actions in 2017. 
This will ensure initiatives are 
added, cancelled and amended as 
appropriate, to reflect changes in 
AOD issues and evidence on the 
effectiveness of interventions.
Priority area 1: 
creating a people-
centred intervention 
system
This priority area involves creating 
an AOD intervention system that 
responds to people at their place 
of need, as early, efficiently and 
effectively as possible. For people 
living with AOD addiction or 
dependence this may mean 
accessible, high-quality addiction 
treatment services, access to 
housing or counselling services. 
But we also don’t want to wait for 
people to be in crisis, or for young 
people to adopt habits that will 
become problematic in later life. 
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The Prime Minister’s Youth Mental 
Health Project introduced national 
waiting time targets for 12–19 year 
olds to be seen within three weeks 
of contacting a youth alcohol and 
drug service and with eight weeks 
of referral from a service. Initial 
results show that youth are being 
provided with better access to 
timely and appropriate treatment 
and follow-up (Ministry of Health 
2014). However, we need to 
continue to monitor this to avoid 
access slipping.
All many people may need is reliable, 
internet-based information, or their 
family doctor or school nurse asking 
about their drinking and drug-taking 
habits and providing advice. For 
children of parents with addiction 
issues, it could be that a specific 
plan is required to ensure their 
needs are looked after. 
In order to make the most of 
opportunities to build resilience 
(eg. through peer support, positive 
role-modelling and confidence-
building programmes) and 
intervene (eg. through the 
provision of information and by 
connecting people to AOD 
treatment) we will need to: 
 → be clear about the roles, 
responsibilities and 
opportunities for individuals, 
families and community 
organisations to prevent and 
reduce AOD-related harm
 → identify and connect referral 
pathways so that ‘any door is  
the right door’
 → know what works, including 
opportunities to intervene 
earlier, and tailoring activities  
to different populations and 
needs across life stages
 → identify the settings that  
are needed to better support 
individuals, community 
organisations and services  
to carry out their roles and 
responsibilities for the  
greatest impact.
By 2017/18 the Government will:
Action Date Strategies
Develop a system map of potential resilience and intervention points  
across a person’s life stages
2016/17
Develop and implement a strategic framework for adult and youth  
AOD services
2017/18
Regularly disseminate case studies of good and innovative practice Annual
Develop common tools and/or forums to share practice and celebrate 
success to foster system learning and improvement
2017/18
Develop initiatives and an implementation plan to improve outcomes  
for the children of parents with mental illness and addiction
2017/18
These actions will integrate closely 
with the Government’s Rising to 
the Challenge plan for mental 
health and addiction services, and 
the new ways of working to target 
government services and provide 
wrap-around responses through 
the Government’s Better Public 
Services Result Areas.
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Priority area 2: 
shifting thinking 
and behaviour
This priority area involves 
encouraging a positive shift in 
thinking and behaviour in New 
Zealand in relation to:
 → the culture of drinking and 
intoxication, including during 
pregnancy
 → help seeking
 → the way in which the system 
intervenes to help.
If we are going to achieve real 
change, then, just like smoking, 
AOD misuse needs to become less 
desirable and help-seeking 
encouraged with the right support 
available at the right time. Social 
sector agencies also need to work 
together to identify people who 
need additional support and tailor 
responses and services to their 
needs. This includes young people 
whose schooling is impacted by 
AOD use, people not in education 
or employment, and people 
affected by a fetal alcohol 
spectrum disorder.
Making progress in this area will 
require sustained effort over a 
considerable period. Change will be 
gradual, but efforts in this area will 
be vital in the long term. 
Communities play an integral role 
in mobilising and sustaining 
change, so we will also develop a 
set of actions that builds the 
capacity and capability of 
communities, particularly those 
most affected by AOD use and 
related harm.
By 2017/18 the Government will:
Action Date Strategies
Build on existing AOD-related public education campaigns to shift  
AOD culture, promote help-seeking and address stigma
Ongoing
Publish a Fetal Alcohol Spectrum Disorders Action Plan 2015/16
Provide guidance to support schools dealing with AOD issues and  
helping students who need it, with a focus on keeping students engaged, 
where possible
2015/16
Develop guidance for improving AOD intervention for services engaging 
with young people not in education or employment
2016/17
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Priority area 3: 
getting the legal 
balance right
This priority area involves  
ensuring we monitor and evaluate 
how well legislation – and its 
implementation – is working for 
individuals, communities and 
society so that we can provide the 
right support and make changes 
where they are needed.
Legislation and law enforcement 
acts to prevent and deter people 
from accessing and using AOD 
harmfully. Laws set the boundaries 
of what can be legally sold and 
under what circumstances and 
whether penalties enable health-
oriented responses where an 
offence has been committed. 
For example:
 → recent changes to the 
regulation of alcohol and 
psychoactive substances have 
set national requirements, while 
giving communities a greater 
say about where and when 
these products will be sold
 → the pilot for the Alcohol and 
Other Drug Treatment Court 
offers offenders the opportunity 
to enter an intensive treatment 
programme for their AOD 
dependency with frequent, 
random drug testing, and, if their 
participation is successful, for 
this to be taken into account 
when they are sentenced. 
The enforcement of the Misuse of 
Drugs Act 1975 also provides scope 
to offer low-level offenders 
alternatives to the criminal justice 
system. For example, a study into 
cannabis use offences in New 
Zealand between 1991 and 2008 
found a substantial decline in 
arrests, prosecutions and 
convictions for cannabis use over 
that period. This was despite any 
changes to the statutory penalties 
for cannabis use since the 
enactment of the Misuse of Drugs 
Act in 1975 (Wilkins et al 2012). 
By 2017/18 the Government will:
Action Date Strategies
Work with the Expert Advisory Committee on Drugs (EACD) to ensure  
harm minimisation is a central feature of drug classification assessments
2015/16
Review the regulation of controlled drugs for legitimate purposes  
(such as medicines) alongside reviews of the Medicines Act 1981 and  
other therapeutics legislation
2017/18
Develop options for further minimising harm in relation to the offence and 
penalty regime for personal possession within the Misuse of Drugs Act 1975
2017/18
Release a discussion document seeking feedback on appropriate regulation 
of drug utensils
2015/16
Introduce the Substance Addiction (Compulsory Assessment and 
Treatment) Bill to Parliament
2015/16
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By 2017/18 the Government will:
Action Date Strategies
Develop a New Zealand position for the United Nations General Assembly 
Special Session on Drugs 2016
2015/16
Review the effectiveness of new police powers to deal with breaches  
of local alcohol bans introduced through the Local Government (Alcohol 
Reform) Amendment Act 2012
2015/16
Evaluate the Alcohol and other Drug Treatment Court Pilot 2017/18
Commence a review of the policy and operation of the Psychoactive 
Substances Act 2013
2017/18
Priority area 4: 
disrupting  
organised crime 
This priority area involves taking  
a multi-agency approach to disrupt 
the ability of sophisticated 
domestic and trans-national 
organised crime groups to  
operate illicit drug networks in  
New Zealand. It recognises that 
these groups drive the importation, 
manufacture and regular supply of 
chemicals and illicit drugs that both 
sustain and expand the domestic 
illicit drug market. Given the illegal 
nature of these activities, these 
groups are also often associated 
with a range of other offending, 
including violence, crimes against 
property and money laundering.  
As well as contributing to broader 
societal harms, certain families and 
communities are disproportionately 
affected by these activities (for 
example, children living in 
clandestine laboratories).
Disrupting activity as far up the 
supply chain as possible is a 
continuing focus for New Zealand 
enforcement agencies. For example, 
‘Taskforce GHOST’ – an operation  
in December 2013 conducted by 
New Zealand Police, the Organised 
and Financial Crime Agency of  
New Zealand and the New Zealand 
Customs Service – prevented  
578kg of pseudoephedrine and  
16kg of ephedrine entering the 
country and being used in the 
domestic methamphetamine 
manufacturing process. 
To successfully disrupt organised 
crime enforcement efforts must 
be supported by initiatives aimed 
at reducing social harm. These 
initiatives need to address the 
social, economic and cultural 
factors that facilitate the 
recruitment of individuals by 
organised crime groups. We need 
to place emphasis both on building 
resilience in communities with a 
large organised crime presence 
and supporting individuals and 
families to turn away from the 
organised crime environment. 
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We need to maintain our focus on:
 → making it easier for 
communities to report illegal 
activities such as the presence 
of tinny houses and clandestine 
labs and taking prompt action 
to remove these
 → reducing social harm through a 
range of prevention and law 
enforcement actions that are 
supported by improved multi-
agency information-sharing, 
analysis and intelligence
 → reinforcing law enforcement 
efforts to break supply chains 
and sophisticated distribution 
networks
 → strengthening border protection 
efforts to target drug trafficking 
networks
 → reducing the availability of 
chemicals and other specialist 
equipment used by domestic 
drug manufacturers
 → targeting the proceeds from 
illicit drug networks to remove 
the profit motive and prevent 
the financing of further crime.
By 2017/18 the Government will:
Action Date Strategies
Conduct the National Cannabis and Crime Operation to disrupt the activities 
of organised crime groups involved in the cultivation of cannabis 
Annual
Implement the Whole of Government Action Plan on Tackling Gangs 2017/18
Work with authorities in drug source and transit countries to break 
precursor chemical and drug supply chains into New Zealand
Ongoing
Continue multi-agency investigations and targeting operations focussed  
on identified vulnerabilities of key organised crime groups and the drug 
supply chain 
Ongoing
Implement the Organised Crime and Anti-corruption Legislation Bill 
provisions (once enacted) which include initiatives that will assist 
disruption of illicit drug supply, using:
 → a more effective money laundering offence
 → improved detection of drug supply networks through reporting  
of international and large cash transactions to Police
2017/18
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Priority area 5: 
improving 
information flow
The aim of this priority area is to 
improve the use and sharing of 
information we collect so that  
we, communities and individuals, 
can better:
 → understand and respond to the 
causes of harmful AOD use
 → target the right resources and 
initiatives to people in need at 
the right time 
 → collaborate to provide wrap-
around services 
 → assess the effectiveness of 
policy and service responses, 
and make improvements
 → track overall progress towards 
the objectives and goal of this 
Policy and its contribution to 
the government’s wider social 
objectives.
Collection, use and sharing of 
information is vital if we are to 
anticipate and respond to AOD 
issues early and effectively, and 
target policy, interventions, 
services and resources where they 
will have the greatest impact. 
Making information accessible is 
also crucial in order for 
communities to decide the AOD 
issues that are important to them 
and that shape their environment, 
and for individuals to be able to 
make informed choices about their 
own AOD use.
By 2017/18 the Government will:
Action Date Strategies
develop Tier 1 statistics for alcohol and other drug harm 2015/16
develop a multi-agency Early Warning System for the purposes of 
monitoring emerging trends and informing both enforcement and harm 
reduction strategies
2016/17
update the New Zealand Drug Harm Index 2016/17
publish a literature review of population-level AOD impacts and unmet needs 2015/16
develop and implement an AOD information plan 2016/17
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Summary of Government actions
Action Year
Priority Area 1 – Creating a people-centred intervention system
 → develop a system map of potential resilience and intervention points across  
a person’s life stages
2016/17
 → develop and implement a strategic framework for adult and youth AOD services 2017/18
 → regularly disseminate case studies of good and innovative practice Annual
 → develop common tools and/or forums to share practice and celebrate success  
to foster system learning and improvement
2017/18
 → develop initiatives and an implementation plan to improve outcomes for children  
of parents with mental illness and addiction
2017/18
Priority Area 2 – Shifting thinking and behaviour
 → build on existing AOD-related public education campaigns to change culture,  
promote help seeking and address stigma
Ongoing
 → publish a Fetal Alcohol Spectrum Disorders Action Plan 2015/16
 → provide guidance to support schools dealing with AOD issues and helping students  
who need it, with a focus on keeping students engaged where possible
2016/17
 → develop guidance for improving AOD intervention for services engaging with young  
people not in education or employment
2016/17
Priority Area 3 – Getting the legal balance right
 → work with the Expert Advisory Committee on Drugs to ensure that harm minimisation  
is a central feature of drug classification assessments 
2015/16
 → review the regulation of controlled drugs for legitimate purposes (such as medicines) 
alongside reviews of the Medicines Act and other therapeutics legislation
2017/18
 → develop options for further minimising harm in relation to the offence and penalty  
regime for personal possession within the Misuse of Drugs Act 1975.
2017/18
 → release a discussion document seeking feedback on appropriate regulation of drug utensils 2015/16
 → introduce the Substance Addiction (Compulsory Assessment and Treatment) Bill to 
Parliament
2015/16
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Action Year
 → develop a New Zealand position for United Nations General Assembly Special Session  
on Drugs 2016
2015/16
 → review the effectiveness of new police powers to deal with breaches of local alcohol bans 
introduced through the Local Government (Alcohol Reform) Amendment Act 2012
2015/16
 → evaluate the Alcohol and other Drug Treatment Court Pilot 2017/18
 → commence a review of the policy and operation of the Psychoactive Substances Act 2013 2017/18
Priority Area 4 – Disrupting organised crime
 → conduct the National Cannabis and Crime Operation to disrupt the activities of organised 
crime groups involved in the cultivation of cannabis
Annual
 → implement the Whole of Government Action Plan on Tackling Gangs 2017/18
 → work with authorities in drug source and transit countries to break precursor chemical  
and drug supply chains into New Zealand
Ongoing
 → continue multi-agency investigations and targeting operations focussed on identified 
vulnerabilities of key organised crime groups and the supply chain
Ongoing
 → implement the Organised Crime and Anti-corruption Legislation Bill provisions 2017/18
Priority Area 5 – Improving information flow
 → develop Tier 1 statistics for alcohol and other drug harm 2015/16
 → develop a multi-agency Early Warning System to monitor emerging trends and inform 
enforcement and harm reduction strategies
2016/17
 → update the New Zealand Drug Harm Index 2016/17
 → publish a literature review of population level AOD impacts and unmet needs 2015/16
 → develop and implement an AOD information plan 2016/17
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